GlaxoSmithKline (GSK) and Dentsply International have entered into an agreement to create a portfolio of co-branded oral care products to be used in the dental office by patients suffering from tooth sensitivity. The agreement will allow Dentsply to co-brand its Nupro products which contain GSK’s NovaMin technology, with GSK’s Sensodyne brand.This co-branding will provide a continuum of care for tooth sensitivity treatment from the dental office to everyday use at home, according to the com...